	US 12,251,405 B2
	Spray dried follistatin product
Maghsoud Dariani, Cedar Knolls, NJ (US); Neerav Padliya, Cedar Knolls, NJ (US); and Alexander Tess, Cedar Knolls, NJ (US)
Assigned to MYOS CORP., Cedar Knolls, NJ (US)
Filed by MYOS RENS TECHNOLOGY INC., Cedar Knolls, NJ (US)
Filed on Oct. 4, 2018, as Appl. No. 16/151,601.
Claims priority of provisional application 62/740,517, filed on Oct. 3, 2018.
Prior Publication US 2020/0108102 A1, Apr. 9, 2020
Int. Cl. A61K 35/57 (2015.01); A23B 5/03 (2006.01); A23L 15/00 (2016.01); A23L 33/18 (2016.01)

CPC A61K 35/57 (2013.01) [A23B 5/03 (2013.01); A23L 15/00 (2016.08); A23L 33/18 (2016.08)]

6 Claims

1. A process for production of a powder comprising active avian follistatin for oral ingestion by a subject, said method comprising:

providing avian whole eggs, avian whole egg yolks, avian egg white or avian egg yolk membranes containing active avian follistatin;

homogenizing or agitating the avian whole eggs, avian whole egg yolks, avian egg white, or avian egg yolk membranes to form an emulsion;

spray drying the emulsion with heat at an inlet temperature of about 280° F. to about 390° F. and an outlet temperature of about 160° F. to about 190° F.;

wherein said method produces a powder containing the active avian follistatin determined by enzyme-linked immunosorbent assay (ELISA); and

formulating said powder for oral ingestion by a subject.